Table of Contents Chapter 1 Overview of Circulating Galectin Inhibitor 1.1 Definition of Circulating Galectin Inhibitor in This Report 1.2 Commercial Types of Circulating Galectin Inhibitor 1.2.1 Natural 1.2.2 Synthesis 1.3 Downstream Application of Circulating Galectin Inhibitor 1.3.1 Cancer 1.3.2 Viral Infection 1.3.3 Liver Disease 1.3.4 Neurodegenerative Disease 1.3.5 Cardiovascular Diseases 1.4 Development History of Circulating Galectin Inhibitor 1.5 Market Status and Trend of Circulating Galectin Inhibitor 2019-2028 1.5.1 Global Circulating Galectin Inhibitor Market Status and Trend 2019-2028 1.5.2 Regional Circulating Galectin Inhibitor Market Status and Trend 2019-2028 Chapter 2 Global Market Status and Forecast by Regions 2.1 Market Development of Circulating Galectin Inhibitor 2019-2023 2.2 Sales Market of Circulating Galectin Inhibitor by Regions 2.2.1 Sales Volume of Circulating Galectin Inhibitor by Regions 2.2.2 Sales Value of Circulating Galectin Inhibitor by Regions 2.3 Production Market of Circulating Galectin Inhibitor by Regions 2.4 Global Market Forecast of Circulating Galectin Inhibitor 2024-2028 2.4.1 Global Market Forecast of Circulating Galectin Inhibitor 2024-2028 2.4.2 Market Forecast of Circulating Galectin Inhibitor by Regions 2024-2028 Chapter 3 Global Market Status and Forecast by Types 3.1 Sales Volume of Circulating Galectin Inhibitor by Types 3.2 Sales Value of Circulating Galectin Inhibitor by Types 3.3 Market Forecast of Circulating Galectin Inhibitor by Types Chapter 4 Global Market Status and Forecast by Downstream Industry 4.1 Global Sales Volume of Circulating Galectin Inhibitor by Downstream Industry 4.2 Global Market Forecast of Circulating Galectin Inhibitor by Downstream Industry Chapter 5 North America Market Status by Countries, Type, Manufacturers and Downstream Industry 5.1 North America Circulating Galectin Inhibitor Market Status by Countries 5.1.1 North America Circulating Galectin Inhibitor Sales by Countries (2019-2023) 5.1.2 North America Circulating Galectin Inhibitor Revenue by Countries (2019-2023) 5.1.3 United States Circulating Galectin Inhibitor Market Status (2019-2023) 5.1.4 Canada Circulating Galectin Inhibitor Market Status (2019-2023) 5.1.5 Mexico Circulating Galectin Inhibitor Market Status (2019-2023) 5.2 North America Circulating Galectin Inhibitor Market Status by Manufacturers 5.3 North America Circulating Galectin Inhibitor Market Status by Type (2019-2023) 5.3.1 North America Circulating Galectin Inhibitor Sales by Type (2019-2023) 5.3.2 North America Circulating Galectin Inhibitor Revenue by Type (2019-2023) 5.4 North America Circulating Galectin Inhibitor Market Status by Downstream Industry (2019-2023) Chapter 6 Europe Market Status by Countries, Type, Manufacturers and Downstream Industry 6.1 Europe Circulating Galectin Inhibitor Market Status by Countries 6.1.1 Europe Circulating Galectin Inhibitor Sales by Countries (2019-2023) 6.1.2 Europe Circulating Galectin Inhibitor Revenue by Countries (2019-2023) 6.1.3 Germany Circulating Galectin Inhibitor Market Status (2019-2023) 6.1.4 UK Circulating Galectin Inhibitor Market Status (2019-2023) 6.1.5 France Circulating Galectin Inhibitor Market Status (2019-2023) 6.1.6 Italy Circulating Galectin Inhibitor Market Status (2019-2023) 6.1.7 Russia Circulating Galectin Inhibitor Market Status (2019-2023) 6.1.8 Spain Circulating Galectin Inhibitor Market Status (2019-2023) 6.1.9 Benelux Circulating Galectin Inhibitor Market Status (2019-2023) 6.2 Europe Circulating Galectin Inhibitor Market Status by Manufacturers 6.3 Europe Circulating Galectin Inhibitor Market Status by Type (2019-2023) 6.3.1 Europe Circulating Galectin Inhibitor Sales by Type (2019-2023) 6.3.2 Europe Circulating Galectin Inhibitor Revenue by Type (2019-2023) 6.4 Europe Circulating Galectin Inhibitor Market Status by Downstream Industry (2019-2023) Chapter 7 Asia Pacific Market Status by Countries, Type, Manufacturers and Downstream Industry 7.1 Asia Pacific Circulating Galectin Inhibitor Market Status by Countries 7.1.1 Asia Pacific Circulating Galectin Inhibitor Sales by Countries (2019-2023) 7.1.2 Asia Pacific Circulating Galectin Inhibitor Revenue by Countries (2019-2023) 7.1.3 China Circulating Galectin Inhibitor Market Status (2019-2023) 7.1.4 Japan Circulating Galectin Inhibitor Market Status (2019-2023) 7.1.5 India Circulating Galectin Inhibitor Market Status (2019-2023) 7.1.6 Southeast Asia Circulating Galectin Inhibitor Market Status (2019-2023) 7.1.7 Australia Circulating Galectin Inhibitor Market Status (2019-2023) 7.2 Asia Pacific Circulating Galectin Inhibitor Market Status by Manufacturers 7.3 Asia Pacific Circulating Galectin Inhibitor Market Status by Type (2019-2023) 7.3.1 Asia Pacific Circulating Galectin Inhibitor Sales by Type (2019-2023) 7.3.2 Asia Pacific Circulating Galectin Inhibitor Revenue by Type (2019-2023) 7.4 Asia Pacific Circulating Galectin Inhibitor Market Status by Downstream Industry (2019-2023) Chapter 8 Latin America Market Status by Countries, Type, Manufacturers and Downstream Industry 8.1 Latin America Circulating Galectin Inhibitor Market Status by Countries 8.1.1 Latin America Circulating Galectin Inhibitor Sales by Countries (2019-2023) 8.1.2 Latin America Circulating Galectin Inhibitor Revenue by Countries (2019-2023) 8.1.3 Brazil Circulating Galectin Inhibitor Market Status (2019-2023) 8.1.4 Argentina Circulating Galectin Inhibitor Market Status (2019-2023) 8.1.5 Colombia Circulating Galectin Inhibitor Market Status (2019-2023) 8.2 Latin America Circulating Galectin Inhibitor Market Status by Manufacturers 8.3 Latin America Circulating Galectin Inhibitor Market Status by Type (2019-2023) 8.3.1 Latin America Circulating Galectin Inhibitor Sales by Type (2019-2023) 8.3.2 Latin America Circulating Galectin Inhibitor Revenue by Type (2019-2023) 8.4 Latin America Circulating Galectin Inhibitor Market Status by Downstream Industry (2015-2019) Chapter 9 Middle East and Africa Market Status by Countries, Type, Manufacturers and Downstream Industry 9.1 Middle East and Africa Circulating Galectin Inhibitor Market Status by Countries 9.1.1 Middle East and Africa Circulating Galectin Inhibitor Sales by Countries (2019-2023) 9.1.2 Middle East and Africa Circulating Galectin Inhibitor Revenue by Countries (2019-2023) 9.1.3 Middle East Circulating Galectin Inhibitor Market Status (2019-2023) 9.1.4 Africa Circulating Galectin Inhibitor Market Status (2019-2023) 9.2 Middle East and Africa Circulating Galectin Inhibitor Market Status by Manufacturers 9.3 Middle East and Africa Circulating Galectin Inhibitor Market Status by Type (2019-2023) 9.3.1 Middle East and Africa Circulating Galectin Inhibitor Sales by Type (2019-2023) 9.3.2 Middle East and Africa Circulating Galectin Inhibitor Revenue by Type (2019-2023) 9.4 Middle East and Africa Circulating Galectin Inhibitor Market Status by Downstream Industry (2019-2023) Chapter 10 Market Driving Factor Analysis of Circulating Galectin Inhibitor 10.1 Global Economy Situation and Trend Overview 10.2 Circulating Galectin Inhibitor Downstream Industry Situation and Trend Overview Chapter 11 Circulating Galectin Inhibitor Market Competition Status by Major Manufacturers 11.1 Production Volume of Circulating Galectin Inhibitor by Major Manufacturers 11.2 Production Value of Circulating Galectin Inhibitor by Major Manufacturers 11.3 Basic Information of Circulating Galectin Inhibitor by Major Manufacturers 11.3.1 Headquarters Location and Established Time of Circulating Galectin Inhibitor Major Manufacturer 11.3.2 Employees and Revenue Level of Circulating Galectin Inhibitor Major Manufacturer 11.4 Market Competition News and Trend 11.4.1 Merger, Consolidation or Acquisition News 11.4.2 Investment or Disinvestment News 11.4.3 New Product Development and Launch Chapter 12 Circulating Galectin Inhibitor Major Manufacturers Introduction and Market Data 12.1 BioXyTran 12.1.1 Company profile 12.1.2 Representative Circulating Galectin Inhibitor Product 12.1.3 Circulating Galectin Inhibitor Sales, Revenue, Price and Gross Margin of BioXyTran 12.2 G3 Pharmaceuticals 12.2.1 Company profile 12.2.2 Representative Circulating Galectin Inhibitor Product 12.2.3 Circulating Galectin Inhibitor Sales, Revenue, Price and Gross Margin of G3 Pharmaceuticals 12.3 Galectin Therapeutics 12.3.1 Company profile 12.3.2 Representative Circulating Galectin Inhibitor Product 12.3.3 Circulating Galectin Inhibitor Sales, Revenue, Price and Gross Margin of Galectin Therapeutics 12.4 Galecto 12.4.1 Company profile 12.4.2 Representative Circulating Galectin Inhibitor Product 12.4.3 Circulating Galectin Inhibitor Sales, Revenue, Price and Gross Margin of Galecto 12.5 GlycoMimetics 12.5.1 Company profile 12.5.2 Representative Circulating Galectin Inhibitor Product 12.5.3 Circulating Galectin Inhibitor Sales, Revenue, Price and Gross Margin of GlycoMimetics 12.6 HiFiBiO 12.6.1 Company profile 12.6.2 Representative Circulating Galectin Inhibitor Product 12.6.3 Circulating Galectin Inhibitor Sales, Revenue, Price and Gross Margin of HiFiBiO 12.7 PureTech Health 12.7.1 Company profile 12.7.2 Representative Circulating Galectin Inhibitor Product 12.7.3 Circulating Galectin Inhibitor Sales, Revenue, Price and Gross Margin of PureTech Health 12.8 TrueBinding 12.8.1 Company profile 12.8.2 Representative Circulating Galectin Inhibitor Product 12.8.3 Circulating Galectin Inhibitor Sales, Revenue, Price and Gross Margin of TrueBinding 12.9 University Medical Center Groningen 12.9.1 Company profile 12.9.2 Representative Circulating Galectin Inhibitor Product 12.9.3 Circulating Galectin Inhibitor Sales, Revenue, Price and Gross Margin of University Medical Center Groningen 12.10 University Of Michigan Medical School 12.10.1 Company profile 12.10.2 Representative Circulating Galectin Inhibitor Product 12.10.3 Circulating Galectin Inhibitor Sales, Revenue, Price and Gross Margin of University Of Michigan Medical School Chapter 13 Upstream and Downstream Market Analysis of Circulating Galectin Inhibitor 13.1 Industry Chain of Circulating Galectin Inhibitor 13.2 Upstream Market and Representative Companies Analysis 13.3 Downstream Market and Representative Companies Analysis Chapter 14 Cost and Gross Margin Analysis of Circulating Galectin Inhibitor 14.1 Cost Structure Analysis of Circulating Galectin Inhibitor 14.2 Raw Materials Cost Analysis of Circulating Galectin Inhibitor 14.3 Labor Cost Analysis of Circulating Galectin Inhibitor 14.4 Manufacturing Expenses Analysis of Circulating Galectin Inhibitor Chapter 15 Report Conclusion Chapter 16 Research Methodology and Reference 16.1 Methodology/Research Approach 16.1.1 Research Programs/Design 16.1.2 Market Size Estimation 16.1.3 Market Breakdown and Data Triangulation 16.2 Data Source 16.2.1 Secondary Sources 16.2.2 Primary Sources 16.3 Reference

List of Tables Table Advantage and Disadvantage of Natural Table Advantage and Disadvantage of Synthesis Table Sales Volume of Circulating Galectin Inhibitor by Regions 2019-2023 Table Sales Value of Circulating Galectin Inhibitor by Regions 2019-2023 Table Production Volume of Circulating Galectin Inhibitor by Regions 2019-2023 Table Global Sales Volume of Circulating Galectin Inhibitor by Regions 2024-2028 Table Global Sales Value of Circulating Galectin Inhibitor by Regions 2024-2028 Table Global Production Volume of Circulating Galectin Inhibitor by Regions 2024-2028 Table Sales Volume of Circulating Galectin Inhibitor by Types 2019-2023 Table Sales Value of Circulating Galectin Inhibitor by Types 2019-2023 Table Sales Volume Forecast of Circulating Galectin Inhibitor by Types 2024-2028 Table Sales Value Forecast of Circulating Galectin Inhibitor by Types 2024-2028 Table Sales Volume of Circulating Galectin Inhibitor by Downstream Industry 2019-2023 Table Sales Volume Forecast of Circulating Galectin Inhibitor by Downstream Industry 2024-2028 Table North America Circulating Galectin Inhibitor Sales by Countries (2019-2023) Table North America Circulating Galectin Inhibitor Sales Share by Countries (2019-2023) Table North America Circulating Galectin Inhibitor Revenue by Countries (2019-2023) Table North America Circulating Galectin Inhibitor Revenue Market Share by Countries (2019-2023) Table North America Circulating Galectin Inhibitor Sales by Type (2019-2023) Table North America Circulating Galectin Inhibitor Sales Share by Type (2019-2023) Table North America Circulating Galectin Inhibitor Revenue by Type (2019-2023) Table North America Circulating Galectin Inhibitor Revenue Share by Type (2019-2023) Table North America Circulating Galectin Inhibitor Sales by Downstream Industry (2019-2023) Table North America Circulating Galectin Inhibitor Sales Share by Downstream Industry (2019-2023) Table Europe Circulating Galectin Inhibitor Sales by Countries (2019-2023) Table Europe Circulating Galectin Inhibitor Sales Share by Countries (2019-2023) Table Europe Circulating Galectin Inhibitor Revenue by Countries (2019-2023) Table Europe Circulating Galectin Inhibitor Revenue Market Share by Countries (2019-2023) Table Europe Circulating Galectin Inhibitor Sales by Type (2019-2023) Table Europe Circulating Galectin Inhibitor Sales Share by Type (2019-2023) Table Europe Circulating Galectin Inhibitor Revenue by Type (2019-2023) Table Europe Circulating Galectin Inhibitor Revenue Share by Type (2019-2023) Table Europe Circulating Galectin Inhibitor Sales by Downstream Industry (2019-2023) Table Europe Circulating Galectin Inhibitor Sales Share by Downstream Industry (2019-2023) Table Asia Pacific Circulating Galectin Inhibitor Sales by Countries (2019-2023) Table Asia Pacific Circulating Galectin Inhibitor Sales Share by Countries (2019-2023) Table Asia Pacific Circulating Galectin Inhibitor Revenue by Countries (2019-2023) Table Asia Pacific Circulating Galectin Inhibitor Revenue Market Share by Countries (2019-2023) Table Asia Pacific Circulating Galectin Inhibitor Sales by Type (2019-2023) Table Asia Pacific Circulating Galectin Inhibitor Sales Share by Type (2019-2023) Table Asia Pacific Circulating Galectin Inhibitor Revenue by Type (2019-2023) Table Asia Pacific Circulating Galectin Inhibitor Revenue Share by Type (2019-2023) Table Asia Pacific Circulating Galectin Inhibitor Sales by Downstream Industry (2019-2023) Table Asia Pacific Circulating Galectin Inhibitor Sales Share by Downstream Industry (2019-2023) Table Latin America Circulating Galectin Inhibitor Sales by Countries (2019-2023) Table Latin America Circulating Galectin Inhibitor Sales Share by Countries (2019-2023) Table Latin America Circulating Galectin Inhibitor Revenue by Countries (2019-2023) Table Latin America Circulating Galectin Inhibitor Revenue Market Share by Countries (2019-2023) Table Latin America Circulating Galectin Inhibitor Sales by Type (2019-2023) Table Latin America Circulating Galectin Inhibitor Sales Share by Type (2019-2023) Table Latin America Circulating Galectin Inhibitor Revenue by Type (2019-2023) Table Latin America Circulating Galectin Inhibitor Revenue Share by Type (2019-2023) Table Latin America Circulating Galectin Inhibitor Sales by Downstream Industry (2019-2023) Table Latin America Circulating Galectin Inhibitor Sales Share by Downstream Industry (2019-2023) Table Middle East and Africa Circulating Galectin Inhibitor Sales by Regions (2019-2023) Table Middle East and Africa Circulating Galectin Inhibitor Sales Share by Regions (2019-2023) Table Middle East and Africa Circulating Galectin Inhibitor Revenue by Regions (2019-2023) Table Middle East and Africa Circulating Galectin Inhibitor Revenue Market Share by Regions (2019-2023) Table Middle East and Africa Circulating Galectin Inhibitor Sales by Type (2019-2023) Table Middle East and Africa Circulating Galectin Inhibitor Sales Share by Type (2019-2023) Table Middle East and Africa Circulating Galectin Inhibitor Revenue by Type (2019-2023) Table Middle East and Africa Circulating Galectin Inhibitor Revenue Share by Type (2019-2023) Table Middle East and Africa Circulating Galectin Inhibitor Sales by Downstream Industry (2019-2023) Table Middle East and Africa Circulating Galectin Inhibitor Sales Share by Downstream Industry (2019-2023) Table Production Volume of Circulating Galectin Inhibitor by Major Manufacturers 2019-2023 Table Production Value of Circulating Galectin Inhibitor by Major Manufacturers 2019-2023 Table Headquarters Location and Established Time of Circulating Galectin Inhibitor Major Manufacturer Table Employees and Revenue Level of Circulating Galectin Inhibitor Major Manufacturer Table Representative Circulating Galectin Inhibitor Product One of BioXyTran Table Representative Circulating Galectin Inhibitor Product Two of BioXyTran Table Circulating Galectin Inhibitor Sales, Revenue, Price and Gross Margin of BioXyTran 2019-2023 Table Representative Circulating Galectin Inhibitor Product One of G3 Pharmaceuticals Table Representative Circulating Galectin Inhibitor Product Two of G3 Pharmaceuticals Table Circulating Galectin Inhibitor Sales, Revenue, Price and Gross Margin of G3 Pharmaceuticals 2019-2023 Table Representative Circulating Galectin Inhibitor Product One of Galectin Therapeutics Table Representative Circulating Galectin Inhibitor Product Two of Galectin Therapeutics Table Circulating Galectin Inhibitor Sales, Revenue, Price and Gross Margin of Galectin Therapeutics 2019-2023 Table Representative Circulating Galectin Inhibitor Product One of Galecto Table Representative Circulating Galectin Inhibitor Product Two of Galecto Table Circulating Galectin Inhibitor Sales, Revenue, Price and Gross Margin of Galecto 2019-2023 Table Representative Circulating Galectin Inhibitor Product One of GlycoMimetics Table Representative Circulating Galectin Inhibitor Product Two of GlycoMimetics Table Circulating Galectin Inhibitor Sales, Revenue, Price and Gross Margin of GlycoMimetics 2019-2023 Table Representative Circulating Galectin Inhibitor Product One of HiFiBiO Table Representative Circulating Galectin Inhibitor Product Two of HiFiBiO Table Circulating Galectin Inhibitor Sales, Revenue, Price and Gross Margin of HiFiBiO 2019-2023 Table Representative Circulating Galectin Inhibitor Product One of PureTech Health Table Representative Circulating Galectin Inhibitor Product Two of PureTech Health Table Circulating Galectin Inhibitor Sales, Revenue, Price and Gross Margin of PureTech Health 2019-2023 Table Representative Circulating Galectin Inhibitor Product One of TrueBinding Table Representative Circulating Galectin Inhibitor Product Two of TrueBinding Table Circulating Galectin Inhibitor Sales, Revenue, Price and Gross Margin of TrueBinding 2019-2023 Table Representative Circulating Galectin Inhibitor Product One of University Medical Center Groningen Table Representative Circulating Galectin Inhibitor Product Two of University Medical Center Groningen Table Circulating Galectin Inhibitor Sales, Revenue, Price and Gross Margin of University Medical Center Groningen 2019-2023 Table Representative Circulating Galectin Inhibitor Product One of University Of Michigan Medical School Table Representative Circulating Galectin Inhibitor Product Two of University Of Michigan Medical School Table Circulating Galectin Inhibitor Sales, Revenue, Price and Gross Margin of University Of Michigan Medical School 2019-2023

BioXyTran G3 Pharmaceuticals Galectin Therapeutics Galecto GlycoMimetics HiFiBiO PureTech Health TrueBinding University Medical Center Groningen University Of Michigan Medical School